RECCE PHARMACEUTICALS LTD — Capital/Financing Update 2024

Apr 15, 2024

ASX Announcement

==> picture [416 x 93] intentionally omitted <==

16 April 2024

Cleansing notice under section 708A(5)(e) of the Corporations Act

Recce Pharmaceuticals Ltd ( ASX:RCE ) ( Recce or Company ) has today issued 250,000 fully paid ordinary shares ( New Shares ) to a consultant in lieu of cash payment for services provided to the Company as detailed in the Appendix 2A.

The Company gives this notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) ( Corporations Act ) and advises that:

• (a) the New Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act;

• (b) as at the date of this notice, the Company has complied with:

  • i. the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

  • ii. section 674 of the Corporations Act; and

• (c) as at the date of this notice, there is no information that is ‘excluded information’ (within the meaning of sections 708A(7) and 708A(8) of the Corporations Act) that is required to be set out in this notice.

This announcement has been approved for release by the Board.

For more information, please contact:

Maggie Niewidok Company Secretary

==> picture [467 x 44] intentionally omitted <==